Published in Surv Ophthalmol on November 01, 2008
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol (2010) 1.45
Current understanding of conventional outflow dysfunction in glaucoma. Curr Opin Ophthalmol (2012) 1.40
Prostaglandin-induced cystoid macular edema following routine cataract extraction. J Ophthalmol (2010) 1.09
Extracellular release of ATP mediated by cyclic mechanical stress leads to mobilization of AA in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2009) 1.07
Analyzing live cellularity in the human trabecular meshwork. Invest Ophthalmol Vis Sci (2013) 1.06
Feline glaucoma--a comprehensive review. Vet Ophthalmol (2011) 1.05
Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. Mol Vis (2011) 0.99
Latanoprost in the treatment of glaucoma. Clin Ophthalmol (2014) 0.95
Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study. BMC Ophthalmol (2010) 0.95
[Development of the iridocorneal angle and congenital glaucoma]. Ophthalmologe (2011) 0.93
Head-down posture induces PERG alterations in early glaucoma. J Glaucoma (2013) 0.91
Pharmaceutical intervention for myopia control. Expert Rev Ophthalmol (2010) 0.90
Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure. BMJ Open (2012) 0.90
Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use. J Ocul Pharmacol Ther (2010) 0.88
Glaucoma management: relative value and place in therapy of available drug treatments. Ther Adv Chronic Dis (2014) 0.87
Expression profile of the matricellular protein osteopontin in primary open-angle glaucoma and the normal human eye. Invest Ophthalmol Vis Sci (2011) 0.87
Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci (2013) 0.87
Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles. Invest Ophthalmol Vis Sci (2014) 0.87
Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure. Clin Ophthalmol (2015) 0.86
A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features. PLoS One (2013) 0.86
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus. Patient Prefer Adherence (2014) 0.85
Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles. Eur J Pharm Biopharm (2015) 0.85
Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides. Clin Ophthalmol (2009) 0.85
Phospholipid profiles of control and glaucomatous human aqueous humor. Biochimie (2014) 0.84
[Effectiveness of selective laser trabeculoplasty in patients with insufficient control of intraocular pressure despite maximum tolerated medical therapy]. Ophthalmologe (2012) 0.84
Effects of prostaglandin analogues on aqueous humor outflow pathways. J Ocul Pharmacol Ther (2013) 0.81
The diurnal and nocturnal effect of travoprost with sofZia on intraocular pressure and ocular perfusion pressure. Am J Ophthalmol (2013) 0.81
Emerging functions of pannexin 1 in the eye. Front Cell Neurosci (2014) 0.81
Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases. BMC Ophthalmol (2016) 0.80
Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats. Vet Ophthalmol (2015) 0.80
Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study. PLoS One (2015) 0.80
Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model. PLoS One (2012) 0.79
Clinical options for the reduction of elevated intraocular pressure. Ophthalmol Eye Dis (2012) 0.79
Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma. Clin Ophthalmol (2012) 0.79
A comparison of trabecular meshwork sphingolipids and ceramides of ocular normotensive and hypertensive states of DBA/2J mice. J Ocul Pharmacol Ther (2013) 0.79
Is There Any Role for the Choroid in Glaucoma? J Glaucoma (2016) 0.78
Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. Open Ophthalmol J (2012) 0.78
Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study. Graefes Arch Clin Exp Ophthalmol (2014) 0.78
Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol (2014) 0.78
Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells. J Biochem Pharmacol Res (2014) 0.78
A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension. BMC Ophthalmol (2012) 0.78
Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol. Drug Des Devel Ther (2015) 0.78
Sphingolipids and ceramides of mouse aqueous humor: Comparative profiles from normotensive and hypertensive DBA/2J mice. Biochimie (2014) 0.77
Imaging the effects of prostaglandin analogues on cultured trabecular meshwork cells by coherent anti-stokes Raman scattering. Invest Ophthalmol Vis Sci (2013) 0.77
The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies. Clin Ophthalmol (2014) 0.77
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma. J Ocul Pharmacol Ther (2016) 0.76
Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo. Curr Eye Res (2014) 0.76
Bimatoprost Induced Serous Macular Detachment after Cataract Surgery. Case Rep Ophthalmol Med (2016) 0.75
The role of latanoprost in an inflammatory bowel disease flare. Gastroenterol Rep (Oxf) (2014) 0.75
Neurodegeneration and Neuroprotection in Glaucoma. Yale J Biol Med (2016) 0.75
Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways. PLoS One (2016) 0.75
Mirtogenol potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects. Clin Ophthalmol (2010) 0.75
Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma. Clin Ophthalmol (2016) 0.75
Critical evaluation of latanoprostene bunod in the treatment of glaucoma. Clin Ophthalmol (2016) 0.75
Bilateral serous detachment associated with latanoprost/timolol fixed combination use: a report of one phakic case. Case Rep Ophthalmol Med (2012) 0.75
Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy. Int J Ophthalmol (2016) 0.75
Effect of timolol maleate gel-forming solution on intraocular pressure, pupil diameter, and heart rate in normal and glaucomatous cats. Vet Ophthalmol (2016) 0.75
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost. Invest Ophthalmol Vis Sci (2017) 0.75
Regeneration of optic nerve fibers with unoprostone, a prostaglandin-related antiglaucoma drug, in adult cats. Jpn J Ophthalmol (2013) 0.75
Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term? Int Ophthalmol (2016) 0.75
Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta (2000) 5.39
Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci (1998) 2.43
The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol (1992) 2.19
Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci (1997) 2.04
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology (2003) 1.96
Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology (2004) 1.89
Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci (1997) 1.83
A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins (1994) 1.76
Aqueous humor dynamics in mice. Invest Ophthalmol Vis Sci (2003) 1.73
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J Pharmacol Exp Ther (2003) 1.42
Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract. Br J Ophthalmol (2006) 1.42
Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res (2004) 1.35
Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther (2003) 1.30
Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology (2008) 1.27
Prostamides (prostaglandin-ethanolamides) and their pharmacology. Br J Pharmacol (2007) 1.23
Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res (1996) 1.22
Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol (2002) 1.22
Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci (2002) 1.19
Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha. Exp Eye Res (1988) 1.19
Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J Biol Chem (1993) 1.19
Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci (1991) 1.18
Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci (2003) 1.17
Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res (1998) 1.16
Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments. Am J Ophthalmol (2007) 1.15
Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences. Surv Ophthalmol (2008) 1.14
Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol (1999) 1.13
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2006) 1.12
Effect of latanoprost on outflow facility in the mouse. Invest Ophthalmol Vis Sci (2004) 1.11
Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Invest Ophthalmol Vis Sci (2004) 1.08
Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol (2001) 1.08
Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression. J Biol Chem (2003) 1.07
Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. Invest Ophthalmol Vis Sci (2003) 1.05
Bimatoprost, prostamide activity, and conventional drainage. Invest Ophthalmol Vis Sci (2007) 1.05
Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost. Ophthalmology (2007) 1.05
The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice. Invest Ophthalmol Vis Sci (2005) 1.05
Effect of prostaglandin F2 alpha on aqueous humor dynamics of rabbit, cat, and monkey. Invest Ophthalmol Vis Sci (1984) 1.02
Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells. Exp Eye Res (2005) 1.02
Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment. Arch Ophthalmol (2001) 1.01
Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach. Invest Ophthalmol Vis Sci (2001) 1.01
The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice. Br J Ophthalmol (2006) 1.00
Mechanisms of action of unoprostone on trabecular meshwork contractility. Invest Ophthalmol Vis Sci (2001) 1.00
The effect of prostaglandin F2 alpha on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res (1990) 1.00
Rebound tonometry in conscious, conditioned mice avoids the acute and profound effects of anesthesia on intraocular pressure. J Ocul Pharmacol Ther (2008) 0.99
Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci (2001) 0.98
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest Ophthalmol Vis Sci (2006) 0.97
Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure. J Glaucoma (2007) 0.97
Prostaglandin F2 alpha receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci (1998) 0.97
Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation. J Ocul Pharmacol Ther (2003) 0.96
Effects of latanoprost on rodent intraocular pressure. Exp Eye Res (2006) 0.96
Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci (1995) 0.95
Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery. Ophthalmology (2004) 0.95
Differential effects of vasodilatory prostaglandins on focal adhesions, cytoskeletal architecture, and migration in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 0.95
Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci (2002) 0.95
Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol (1997) 0.94
Enhancement of scleral macromolecular permeability with prostaglandins. Trans Am Ophthalmol Soc (2001) 0.94
The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice. Invest Ophthalmol Vis Sci (2006) 0.94
Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci (2001) 0.93
Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process. Invest Ophthalmol Vis Sci (2005) 0.92
Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. FASEB J (2005) 0.91
Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow. Invest Ophthalmol Vis Sci (2009) 0.91
Effects of prostaglandin analogues on human ciliary muscle and trabecular meshwork cells. Invest Ophthalmol Vis Sci (2003) 0.89
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Invest Ophthalmol Vis Sci (2006) 0.89
Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci (2006) 0.89
The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study. Graefes Arch Clin Exp Ophthalmol (2004) 0.88
Prostaglandin production by human trabecular cells: in vitro inhibition by dexamethasone. Invest Ophthalmol Vis Sci (1983) 0.88
Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription. Br J Pharmacol (2004) 0.87
Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. Surv Ophthalmol (1997) 0.86
Ultrastructural evidence for lymphatic capillaries in the primate choroid. Arch Ophthalmol (1988) 0.86
Arachidonic acid metabolism in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (1988) 0.85
Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork. Exp Eye Res (2005) 0.85
[Electron microscopy and immunohistochemical studies of the intraocular pressure lowering effect of prostaglandin F2 alpha]. Fortschr Ophthalmol (1990) 0.85
Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest Ophthalmol Vis Sci (2002) 0.84
Effects of travoprost on aqueous humor dynamics in monkeys. J Glaucoma (2005) 0.84
Flow after prostaglandin E1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments. Invest Ophthalmol Vis Sci (1999) 0.84
Unoprostone (isopropyl unoprostone) Drugs Aging (1996) 0.84
Increase in outflow facility with unoprostone treatment in ocular hypertensive patients. Arch Ophthalmol (2004) 0.83
Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol (2001) 0.82
A modified in vitro method for aqueous humor outflow studies in enucleated porcine eyes. J Ocul Pharmacol Ther (2007) 0.81
Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes. Invest Ophthalmol Vis Sci (2007) 0.80
Effect of intraocular pressure on uveoscleral outflow following cyclodialysis in the monkey eye. Invest Ophthalmol Vis Sci (1985) 0.80
Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. Arch Ophthalmol (1998) 0.80
Aqueous humor dynamics in monkeys after topical 8-iso PGE(2). Invest Ophthalmol Vis Sci (2004) 0.79
Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous humor dynamics in a nonhuman primate model of glaucoma. J Ocul Pharmacol Ther (2006) 0.79
Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells. Ophthalmic Res (2005) 0.78
Latanoprost versus bimatoprost. Ophthalmology (2003) 0.78
Prostaglandins E1 and E2, but not F2alpha or latanoprost, inhibit monkey ciliary muscle contraction. Curr Eye Res (2005) 0.77
The effect of prostaglandins on the isolated internal muscles of the mammalian eye, including man. Doc Ophthalmol (1977) 0.77
Detection of prostaglandin EP(1), EP(2), and FP receptor subtypes in human sclera. Invest Ophthalmol Vis Sci (2001) 0.77
Viscocanalostomy in rhesus monkeys. Arch Ophthalmol (2004) 2.04
Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res (2003) 1.98
Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res (2005) 1.82
Effect of low-dose latrunculin B on anterior segment physiologic features in the monkey eye. Arch Ophthalmol (2004) 1.58
Research opportunities in vision: a report of the U.S.-Indo workshops on collaborative research. Invest Ophthalmol Vis Sci (2006) 1.46
Accommodative ciliary body and lens function in rhesus monkeys, I: normal lens, zonule and ciliary process configuration in the iridectomized eye. Invest Ophthalmol Vis Sci (2006) 1.39
Imaging and measurement in the eye: now and ahead. Optom Vis Sci (2012) 1.38
Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res (2005) 1.35
Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res (2004) 1.35
The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci (2009) 1.31
Recent developments in understanding the pathophysiology of elevated intraocular pressure. Curr Opin Ophthalmol (2006) 1.29
The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res (2008) 1.28
In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci (2002) 1.25
The zonula, lens, and circumlental space in the normal iridectomized rhesus monkey eye. Invest Ophthalmol Vis Sci (2006) 1.23
Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol (2002) 1.22
Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. Invest Ophthalmol Vis Sci (2009) 1.16
The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis (2005) 1.16
Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res (2006) 1.16
Latrunculin B effects on trabecular meshwork and corneal endothelial morphology in monkeys. Exp Eye Res (2005) 1.13
Morphology and accommodative function of the vitreous zonule in human and monkey eyes. Invest Ophthalmol Vis Sci (2009) 1.12
Eyelid lymphatics II: a search for drainage patterns in the monkey and correlations with human lymphatics. Ophthal Plast Reconstr Surg (2002) 1.12
Lens diameter and thickness as a function of age and pharmacologically stimulated accommodation in rhesus monkeys. Exp Eye Res (2008) 1.11
Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res (2003) 1.11
Functional and structural reversibility of H-7 effects on the conventional aqueous outflow pathway in monkeys. Exp Eye Res (2004) 1.09
Age-related changes in centripetal ciliary body movement relative to centripetal lens movement in monkeys. Exp Eye Res (2009) 1.07
Beta1 and beta3 integrins cooperate to induce syndecan-4-containing cross-linked actin networks in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2006) 1.07
Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells. Exp Eye Res (2006) 1.06
Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways. Invest Ophthalmol Vis Sci (2009) 1.05
Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol Vis Sci (2011) 1.05
Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res (2006) 1.04
Comparison of the Ahmed Glaucoma Valve, the Krupin Eye Valve with Disk, and the double-plate Molteno implant. J Glaucoma (2002) 1.04
Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp Eye Res (2004) 1.03
Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates. Hum Gene Ther (2009) 1.02
Neurochemical correlates of cortical plasticity after unilateral elevated intraocular pressure in a primate model of glaucoma. Invest Ophthalmol Vis Sci (2003) 1.02
Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci (2003) 1.01
Primate glaucoma models. J Glaucoma (2005) 1.00
Extralenticular and lenticular aspects of accommodation and presbyopia in human versus monkey eyes. Invest Ophthalmol Vis Sci (2013) 1.00
Monkey organ-cultured anterior segments: technique and response to H-7. Exp Eye Res (2006) 0.99
Surgical intervention and accommodative responses, II: forward ciliary body accommodative movement is facilitated by zonular attachments to the lens capsule. Invest Ophthalmol Vis Sci (2008) 0.99
Cochlin expression in anterior segment organ culture models after TGFbeta2 treatment. Invest Ophthalmol Vis Sci (2008) 0.96
Aging of the human lens: changes in lens shape upon accommodation and with accommodative loss. J Opt Soc Am A Opt Image Sci Vis (2002) 0.95
Astrocyte and microglial activation in the lateral geniculate nucleus and visual cortex of glaucomatous and optic nerve transected primates. Mol Vis (2009) 0.95
Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy. Br J Ophthalmol (2007) 0.94
Morphologic indication for proprioception in the human ciliary muscle. Invest Ophthalmol Vis Sci (2009) 0.94
Surgical intervention and accommodative responses, I: centripetal ciliary body, capsule, and lens movements in rhesus monkeys of various ages. Invest Ophthalmol Vis Sci (2008) 0.91
Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys. J Ocul Pharmacol Ther (2009) 0.91
Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma. Arch Ophthalmol (2005) 0.91
Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments. Invest Ophthalmol Vis Sci (2008) 0.91
Heparin II domain of fibronectin mediates contractility through an alpha4beta1 co-signaling pathway. Exp Cell Res (2010) 0.91
Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys. Invest Ophthalmol Vis Sci (2003) 0.91
Accommodative movements of the vitreous membrane, choroid, and sclera in young and presbyopic human and nonhuman primate eyes. Invest Ophthalmol Vis Sci (2013) 0.90
Oxidative injury by peroxynitrite in neural and vascular tissue of the lateral geniculate nucleus in experimental glaucoma. Exp Eye Res (2005) 0.90
COCH transgene expression in cultured human trabecular meshwork cells and its effect on outflow facility in monkey organ cultured anterior segments. Invest Ophthalmol Vis Sci (2009) 0.89
Effect of daily prolonged ketamine anesthesia on intraocular pressure in monkeys. Curr Eye Res (2008) 0.89
Molecular cloning and expression profiling of optineurin in the rhesus monkey. Invest Ophthalmol Vis Sci (2005) 0.89
Heritable features of the optic disc: a novel twin method for determining genetic significance. Invest Ophthalmol Vis Sci (2007) 0.88
Effects of latrunculin B on outflow facility, intraocular pressure, corneal thickness, and miotic and accommodative responses to pilocarpine in monkeys. Trans Am Ophthalmol Soc (2004) 0.88
Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci (2008) 0.88
Effect of nitric oxide on anterior segment physiology in monkeys. Invest Ophthalmol Vis Sci (2013) 0.87
Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol (2002) 0.87
Androgen receptor and NFkB expression in human normal and glaucomatous optic nerve head astrocytes in vitro and in experimental glaucoma. Exp Eye Res (2005) 0.86
Accommodation and presbyopia: the ciliary neuromuscular view. Ophthalmol Clin North Am (2006) 0.85
Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine. Trans Am Ophthalmol Soc (2007) 0.85
The prostaglandin wars. Am J Ophthalmol (2003) 0.85
Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys. Arch Ophthalmol (2004) 0.85
Factors affecting outflow facility calculations. Exp Eye Res (2006) 0.85
Gold standard medical therapy for glaucoma: defining the criteria identifying measures for an evidence-based analysis. Clin Ther (2004) 0.85
Multifocal visual evoked potentials in the anesthetized non-human primate. Curr Eye Res (2006) 0.84
Effects of travoprost on aqueous humor dynamics in monkeys. J Glaucoma (2005) 0.84
Serial multifocal electroretinograms during long-term elevation and reduction of intraocular pressure in non-human primates. Doc Ophthalmol (2010) 0.83
Innervation of the uvea by galanin and somatostatin immunoreactive axons in macaques and baboons. Exp Eye Res (2002) 0.83
Gene therapy targeting glaucoma: where are we? Surv Ophthalmol (2009) 0.83
Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther (2013) 0.82
Effect of nitric oxide compounds on monkey ciliary muscle in vitro. Exp Eye Res (2010) 0.82
Comparisons of actin filament disruptors and Rho kinase inhibitors as potential antiglaucoma medications. Expert Rev Ophthalmol (2012) 0.82
Dendrite plasticity in the lateral geniculate nucleus in primate glaucoma. Vision Res (2010) 0.82
Ocular drug delivery: molecules, cells, and genes. Can J Ophthalmol (2007) 0.81
Effects of reference electrode location on monopolar-derived multifocal electroretinograms in cynomolgus monkeys. Doc Ophthalmol (2006) 0.81
A Potential Application of Canaloplasty in Glaucoma Gene Therapy. Transl Vis Sci Technol (2013) 0.81
Effect of H-7 on secondary cataract after phacoemulsification in the live rabbit eye. J Ocul Pharmacol Ther (2010) 0.80
H-7 effect on outflow facility after trabecular obstruction following long-term echothiophate treatment in monkeys. Invest Ophthalmol Vis Sci (2004) 0.80
Aqueous humor dynamics in monkeys after topical R-DOI. Invest Ophthalmol Vis Sci (2005) 0.80
1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates. Arch Biochem Biophys (2011) 0.80